Search results
Found 30669 matches for
Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
Available studentship projects
Applications for this project are now closed.
UCB-Translational Pharmacology Scholarship
Applications for this project are now closed.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
MEET MICHAEL AND STEFAN
-
Michael Dustin
Kennedy Trust Professor of Molecular Immunology
